Gerard Dolan

2.4k total citations
33 papers, 1.6k citations indexed

About

Gerard Dolan is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Gerard Dolan has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 6 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Gerard Dolan's work include Hemophilia Treatment and Research (21 papers), Platelet Disorders and Treatments (7 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Gerard Dolan is often cited by papers focused on Hemophilia Treatment and Research (21 papers), Platelet Disorders and Treatments (7 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Gerard Dolan collaborates with scholars based in United Kingdom, Germany and United States. Gerard Dolan's co-authors include Peter W. Collins, C. R. M. Hay, Simon Brown, David Keeling, Michael Makris, John Hanley, Ri Liesner, Sybil Hirsch, Trevor Baglin and J Wilde and has published in prestigious journals such as New England Journal of Medicine, Blood and Thorax.

In The Last Decade

Gerard Dolan

31 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerard Dolan United Kingdom 17 1.2k 447 215 124 121 33 1.6k
Cristina Santoro Italy 21 1.2k 1.0× 501 1.1× 140 0.7× 245 2.0× 116 1.0× 106 1.5k
Renu Saxena India 21 967 0.8× 417 0.9× 92 0.4× 133 1.1× 81 0.7× 123 1.3k
Meera Chitlur United States 22 938 0.8× 188 0.4× 197 0.9× 90 0.7× 177 1.5× 77 1.4k
J Wilde United Kingdom 18 638 0.5× 237 0.5× 123 0.6× 62 0.5× 205 1.7× 34 1.1k
Britta A. P. Laros‐van Gorkom Netherlands 19 1.0k 0.8× 253 0.6× 105 0.5× 55 0.4× 177 1.5× 49 1.2k
Annette Poon Canada 15 548 0.4× 126 0.3× 84 0.4× 81 0.7× 122 1.0× 33 812
F. Hernández‐Navarro Spain 21 991 0.8× 441 1.0× 85 0.4× 80 0.6× 100 0.8× 58 1.4k
Guillermo J. Ruiz‐Delgado Mexico 17 616 0.5× 203 0.5× 68 0.3× 180 1.5× 65 0.5× 130 953
Saskia E.M. Schols Netherlands 19 676 0.6× 159 0.4× 149 0.7× 62 0.5× 104 0.9× 77 1.0k
A Girolami Italy 20 894 0.7× 275 0.6× 189 0.9× 76 0.6× 268 2.2× 120 1.4k

Countries citing papers authored by Gerard Dolan

Since Specialization
Citations

This map shows the geographic impact of Gerard Dolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard Dolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard Dolan more than expected).

Fields of papers citing papers by Gerard Dolan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerard Dolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard Dolan. The network helps show where Gerard Dolan may publish in the future.

Co-authorship network of co-authors of Gerard Dolan

This figure shows the co-authorship network connecting the top 25 collaborators of Gerard Dolan. A scholar is included among the top collaborators of Gerard Dolan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerard Dolan. Gerard Dolan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laffan, Michael, Paul McLaughlin, Jayashree Motwani, et al.. (2024). Expert United Kingdom consensus on the preservation of joint health in people with moderate and severe haemophilia A: A modified Delphi panel. Haemophilia. 30(2). 306–319.
2.
Gupta, Naresh, Cecil Ross, Chandrakala Shanmukhaiah, et al.. (2024). Expert Opinions on the Management of Hemophilia A in India: The Role of Emicizumab. Cureus. 16(4). e58941–e58941. 3 indexed citations
3.
Dolan, Gerard, et al.. (2024). Nonsevere Hemophilia: The Need for a Renewed Focus and Improved Outcomes. Seminars in Thrombosis and Hemostasis. 51(1). 58–67. 2 indexed citations
4.
5.
Astermark, Jan, Cihan Ay, Manuela Carvalho, et al.. (2021). New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia. Thrombosis and Haemostasis. 122(6). 905–912.
6.
Berntorp, Erik, Gerard Dolan, C. R. M. Hay, et al.. (2016). European retrospective study of real‐life haemophilia treatment. Haemophilia. 23(1). 105–114. 56 indexed citations
7.
Navaratnam, Vidya, Andrew Fogarty, N W Thompson, et al.. (2012). S97 Is an Increased Tendency to Clot a Risk Factor For Developing Idiopathic Pulmonary Fibrosis?. Thorax. 67(Suppl 2). A48.1–A48. 1 indexed citations
8.
Zaman, Shakila, F. G. H. Hill, Ben Palmer, et al.. (2011). The risk of variant Creutzfeldt-Jakob disease among UK patients with bleeding disorders, known to have received potentially contaminated plasma products. Haemophilia. 17(6). 931–937. 20 indexed citations
9.
10.
Dolan, Gerard, Cédric Hermans, Robert Klamroth, et al.. (2008). Challenges and controversies in haemophilia care in adulthood. Haemophilia. 15(s1). 20–27. 25 indexed citations
11.
Dolan, Gerard, et al.. (2008). Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias. Haemophilia. 14(5). 889–897. 26 indexed citations
12.
Pavord, Sue, et al.. (2007). Short communication: Pregnancy outcome in Factor XI deficiency: incidence of miscarriage, antenatal and postnatal haemorrhage in 33 women with Factor XI deficiency. BJOG An International Journal of Obstetrics & Gynaecology. 114(5). 643–646. 37 indexed citations
13.
Knight, R., Samuel L. Stanley, Michael Wong, & Gerard Dolan. (2006). Hemophilia Therapy and Blood-Borne Pathogen Risk. Seminars in Thrombosis and Hemostasis. 32(S 2). 3–9. 12 indexed citations
14.
Collins, Peter W., Sybil Hirsch, Trevor Baglin, et al.. (2006). Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood. 109(5). 1870–1877. 474 indexed citations
15.
Vakalopoulou, Sofia, Vassilios Perifanis, Κωνσταντίνος Τζιόμαλος, et al.. (2006). Management of acute bleeding in a patient with congenital afibrinogenaemia. Haemophilia. 12(6). 676–678. 9 indexed citations
16.
Pasi, John, Paula Bolton‐Maggs, P. Collins, et al.. (2005). A framework for genetic service provision for haemophilia and other inherited bleeding disorders. Haemophilia. 11(2). 145–163. 30 indexed citations
17.
Pasi, John, Paul W. Collins, David Keeling, et al.. (2004). Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization. Haemophilia. 10(3). 218–231. 99 indexed citations
18.
Dolan, Gerard, et al.. (2000). Relapsing polychondritis and myelodysplasia: a report of two cases and review of the current literature. Clinical & Laboratory Haematology. 22(1). 45–48. 10 indexed citations
19.
Milliken, Samuel T., et al.. (1998). A phase II study of liposomal doxorubicin in the treatment of HIV‐related Kaposi's sarcoma. Australian and New Zealand Journal of Medicine. 28(6). 777–783. 18 indexed citations
20.
Dolan, Gerard, M. Greaves, & F E Preston. (1988). 227 Familial plasminogen deficiency and thrombovascular disease. Fibrinolysis and Proteolysis. 2. 97–97. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Santoro Breakdown of academic impact, for papers by Renu Saxena Breakdown of academic impact, for papers by Meera Chitlur Breakdown of academic impact, for papers by J Wilde Breakdown of academic impact, for papers by Britta A. P. Laros‐van Gorkom Breakdown of academic impact, for papers by Annette Poon Breakdown of academic impact, for papers by F. Hernández‐Navarro Breakdown of academic impact, for papers by Guillermo J. Ruiz‐Delgado Breakdown of academic impact, for papers by Saskia E.M. Schols Breakdown of academic impact, for papers by A Girolami
Rankless by CCL
2026